Neuraxis, Inc. (NRXS) vs Seer, Inc. (SEER)
Neuraxis, Inc. and Seer, Inc. are both Biotechnology companies. Neuraxis, Inc. and Seer, Inc. are of similar size ($103.6M and $97.3M). Neuraxis, Inc. grew revenue faster over the last twelve months: 65.2% against −12.7%. Neuraxis, Inc. has the higher net margin (−159.0% vs −478.1%) and the higher return on invested capital (0.00% vs −60.8%). Across the 17 metrics below, Neuraxis, Inc. leads on 10 and Seer, Inc. on 7.
Valuation
Profitability
| Metric | NRXS | SEER | Biotechnology median |
|---|---|---|---|
| Gross margin | 85.56% | 47.70% | 65.16% |
| Operating margin | (144.51%) | (498.19%) | 0.00% |
| Net margin | (159.01%) | (478.05%) | 0.00% |
| Free cash flow margin | (106.10%) | (309.34%) | 0.00% |
| Return on equity | (153.96%) | (26.45%) | (57.72%) |
| Return on assets | (98.96%) | (23.47%) | (49.22%) |
| Return on invested capital | 0.00% | (60.78%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack